US Stock MarketDetailed Quotes

RSLS ReShape Lifesciences

Watchlist
  • 1.0900
  • -0.0700-6.03%
Trading Feb 27 11:46 ET
3.60MMarket Cap-0.11P/E (TTM)

ReShape Lifesciences Key Stats

ReShape Lifesciences Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 1 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
May 15, 20242024/Q11.944M / 2.104M--
--2023/Q41.982M / 2.208M--
Nov 8, 20232023/Q32.155M / 2.400M--
Aug 7, 20232023/Q22.254M / 2.610M--
May 15, 20232023/Q12.287M / 2.513M--
DatePeriodRevenue/EstimateEarnings Call
May 15, 20242024/Q11.944M / 2.104M--
--2023/Q41.982M / 2.208M--
Nov 8, 20232023/Q32.155M / 2.400M--
Aug 7, 20232023/Q22.254M / 2.610M--
May 15, 20232023/Q12.287M / 2.513M--

Unlock Free Earnings Estimates

ReShape Lifesciences Earnings Reports

Read more

Trending Stocks

Top Gaining Chinese Stocks Top Gaining Chinese Stocks
Unlock Now
Discussing
FOMC leaves rates unchanged, how will you adjust your portfolio?
FOMC left the target Federal Funds rate unchanged at at target of 4.25%-4.5%, how will you adjust your portfolio? Show More